Itamar Medical Inc. Products Receive Brazilian ANVISA Certification to Enter South American Market
12/13/2011 7:07:54 AM
CAESAREA, Israel--(BUSINESS WIRE)--Itamar Medical, the world's leading developer of non-invasive technology for early detection of cardiovascular disease and home testing of obstructive sleep apnea, continues to penetrate new markets and has announced a breakthrough in South America by receiving ANVISA certification. The flagship products, WatchPAT and EndoPAT, may now be imported and sold freely to the clinical market of South America.
comments powered by